Jean-Christophe Bélisle-Pipon
Jean-Christophe Bélisle-Pipon
Petrie-Flom Center, Harvard Law School
Verified email at law.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Early-career researchers’ views on ethical dimensions of patient engagement in research
JC Bélisle-Pipon, G Rouleau, S Birko
BMC medical ethics 19 (1), 21, 2018
152018
Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information
JC Bélisle Pipon, B Williams-Jones
Journal of Bioethical Inquiry 12 (2), 259-267, 2015
152015
Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries
JC Bélisle-Pipon, E Vayena, R C. Green, IG Cohen
Nature Medicine, 2019
112019
Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly’s Canadian 40over40 Erectile Dysfunction Campaign
JC Bélisle Pipon, B Williams-Jones
Healthcare Policy 10 (4), 16-22, 2015
112015
Patients as Research Partners; How to Value their Perceptions, Contribution and Labor?
E Smith, JC Bélisle-Pipon, D Resnik
Citizen Science 4 (1), 1-13, 2019
92019
Duty to inform and informed consent in diagnostic radiology: how ethics and law can better guide practice
V Doudenkova, JCB Pipon
Hec Forum 28 (1), 75-94, 2016
92016
Ethics education in public health: where are we now and where are we going?
V Doudenkova, JC Bélisle-Pipon, L Ringuette, V Ravitsky, ...
International Journal of Ethics Education, 2017
82017
Early career researchers’ perspectives and roles in patient-oriented research
G Rouleau, JC Bélisle-Pipon, S Birko, P Karazivan, N Fernandez, ...
Research Involvement and Engagement 4 (1), 35, 2018
62018
Experts sous influence? Quand la non-divulgation des conflits d’intérêts met à risque la confiance du public
B Williams-Jones, JC Bélisle-Pipon, L Ringuette, AI Cloutier, ...
Autour de l’intégrité scientifique, la loyauté, et la probité : aspects …, 2016
52016
De la binarité au modèle AI3R : la bioéthique écosystémique comme modèle d’analyse normative de l’industrie biopharmaceutique
JC Bélisle Pipon
Université de Montréal, 2013
52013
Protecting public health or commercial interests? The importance of transparency during immunization campaigns
JC Bélisle-Pipon, L Ringuette, V Doudenkova, B Williams-Jones
Ethics, Medicine and Public Health, 2017
42017
Conflicts of interest and the (in)dependence of experts advising government on immunization policies
JC Bélisle-Pipon, L Ringuette, AI Cloutier, V Doudenkova, ...
Vaccine, 2018
32018
Merging arts and bioethics: An interdisciplinary experiment in cultural and scientific mediation
V Couture, JC Bélisle-Pipon, M Cloutier, C Barnabé
Bioethics, 616–630, 2017
32017
Améliorer la compréhension et la gestion des conflits d’intérêts des experts conseillant la prise de décisions en santé publique
AI Cloutier, JC Bélisle-Pipon, L Ringuette, V Doudenkova, ...
BioéthiqueOnline 5 (38), 1-5, 2016
32016
Preparing for the arrival of “pink Viagra”: strengthening Canadian direct-to-consumer information regulations
JC Bélisle Pipon, B Williams-Jones
Canadian Medical Association Journal 188 (5), 319-320, 2016
3*2016
Expert Advisory Committees & Conflict of Interest
JC Bélisle-Pipon, L Ringuette, B Williams-Jones
ImpactEthics, 2017
22017
Art + Bioéthique : quand la recherche en bioéthique quitte les murs de l’université
V Couture, JC Bélisle-Pipon, M Laliberté
BioéthiqueOnline 5 (16), 2016
22016
Les enjeux éthiques de la limite des ressources en santé
J Saint-Arnaud, B Godard, JC Bélisle Pipon
Presses de l'Université de Montréal, 2016
22016
Visées éthiques, développement et usage du médicament
JS Fortin, JC Bélisle-Pipon, I Ganache
Précis de pharmacologie, 1011-1021, 2015
22015
Ethical challenges of open-access publishing
B Williams-Jones, JC Bélisle-Pipon, E Smith, R Boulanger
University Affairs, 2014
22014
The system can't perform the operation now. Try again later.
Articles 1–20